Package 0143-9606-01

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 0143-9606-01
Digits Only 0143960601
Product NDC 0143-9606
Description

1 VIAL in 1 CARTON (0143-9606-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2020-06-08
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "592a688f-2e42-4e91-a3ea-34befe2a4e07", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["ff73515d-bd55-4eb5-992b-d2138c80887e"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0143-9606-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "0143-9606-01", "marketing_start_date": "20200608"}], "brand_name": "Azacitidine", "product_id": "0143-9606_592a688f-2e42-4e91-a3ea-34befe2a4e07", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0143-9606", "generic_name": "Azacitidine", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA209337", "marketing_category": "ANDA", "marketing_start_date": "20200608", "listing_expiration_date": "20261231"}